The North American Spine Society on Jan. 29 released guidelines for the diagnosis and treatment of low back pain in adult patients.
The Latest
Here are four orthopedic surgeons making the news this week.
Myeliviz, a new drug to help diagnose multiple sclerosis in its earlier stages was recently approved by the FDA for human clinical trials.
Podiatric surgeon Dan Robinson, DPM, was sworn in as a member of the Blackfoot, Idaho-based Bingham Healthcare board of directors, the Bingham County Chronicle
Orthopedic surgeon Ronald Baker, MD, on Jan. 29 joined Resurgens Orthopaedics in Atlanta.
Collagen Matrix, acquired by private equity firm Linden Capital Partners last year, appointed Shawn McCarthy as CEO on Jan. 29.
Atlas Spine on Jan. 28 launched its V3 Guided Segmental Plating System, expanding treatments for complex deformity and degenerative conditions of the cervical spine.
Lasers may not live up to the hype for treating spinal disorders that cause chronic back pain, according to spine surgeon Kaixuan Liu, MD, PhD.
Park Ridge, Ill.-based The Spine Center welcomed its fourth surgeon, according to a Jan. 28 press release.
Zolgensma, Novartis' gene therapy drug for spinal muscular atrophy, totaled $186 million in fourth quarter sales, according to Stat.